Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary
Already used in Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) for adult patients, Rapiscan is now approved for use in stress Cardiac Magnetic Resonance Imaging (CMR)Rapiscan, a pharmacological stress agent, is an alternative for patients who cannot exerciseCHALFONT ST GILES, E.